Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The impact of cannabinoid type 2 receptors (CB2Rs) in neuroprotection against neurological disorders
Qing Xin, Fei Xu, Devin H. Taylor, et al.
Acta Pharmacologica Sinica (2020) Vol. 41, Iss. 12, pp. 1507-1518
Open Access | Times Cited: 24

Showing 24 citing articles:

New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
Berhanu Geresu Kibret, Hiroki Ishiguro, Yasue Horiuchi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 975-975
Open Access | Times Cited: 45
CB2R Activation Regulates TFEB-Mediated Autophagy and Affects Lipid Metabolism and Inflammation of Astrocytes in POCD
Lieliang Zhang, Xifeng Wang, Wen Yu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36
Potential Role of Cannabinoid Type 2 Receptors in Neuropsychiatric and Neurodegenerative Disorders
Hiroki Ishiguro, Berhanu Geresu Kibret, Yasue Horiuchi, et al.
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 20
Research progress on the cannabinoid type-2 receptor and Parkinson’s disease
Xiao‐Qi Yu, Yi Jia, Yuan Dong
Frontiers in Aging Neuroscience (2024) Vol. 15
Open Access | Times Cited: 4
Cannabinoids as Potential Multitargeting Neuroprotectants in Neuropathic Pain: Exploring the Interplay between Cannabinoid System and Autophagy
Heba‐Tallah Abd Elrahim Abd Elkader, Sara El Idrissi, Sana Sellami, et al.
IntechOpen eBooks (2025)
Closed Access
The endocannabinoid and paracannabinoid systems in natural reward processes: possible pharmacological targets?
Marzia Friuli, Barbara Eramo, C. Sepe, et al.
Physiology & Behavior (2025) Vol. 296, pp. 114929-114929
Closed Access
Neuroinflammation in the Central Nervous System: Exploring the Evolving Influence of Endocannabinoid System
Sumit Rathod, Yogeeta O. Agrawal, Kartik T. Nakhate, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2642-2642
Open Access | Times Cited: 10
Cannabinoids and monoaminergic system: implications for learning and memory
Sha Zhao, Zhaoliang Gu, Ya-Nan Yue, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 3
Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
Barbara Vuić, Tina Milos, Lucija Tudor, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3000-3000
Open Access | Times Cited: 15
First-in-human imaging using [11C]MDTC: a radiotracer targeting the cannabinoid receptor type 2
Yong Du, Jennifer M. Coughlin, Mary Katherine Brosnan, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2023) Vol. 50, Iss. 8, pp. 2386-2393
Closed Access | Times Cited: 8
Cannabinoids: Potential for Modulation and Enhancement When Combined with Vitamin B12 in Case of Neurodegenerative Disorders
Anna Aleksandra Kaszyńska
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 813-813
Open Access | Times Cited: 2
The CB2 Receptor as a Novel Therapeutic Target for Epilepsy Treatment
Xiaoyu Ji, Yang Zeng, Jie Wu
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 16, pp. 8961-8961
Open Access | Times Cited: 17
Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer’s disease
Vasil Kecheliev, Francesco Spinelli, Adrienne Müller Herde, et al.
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 11
Characterization of the Antitumor Potential of Extracts of Cannabis sativa Strains with High CBD Content in Human Neuroblastoma
Laura Sánchez-Sánchez, Javier García, Roberto Fernández, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3837-3837
Open Access | Times Cited: 5
The Role of Cannabinoid Type 2 Receptors in Parkinson’s Disease
Maria Sofia Basile, Emanuela Mazzon
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2986-2986
Open Access | Times Cited: 8
Cannabidiol: metabolism and clinical efficacy in epileptic patients
Giovanni Battista Dell’Isola, Alberto Verrotti, Miriam Sciaccaluga, et al.
Expert Opinion on Drug Metabolism & Toxicology (2024) Vol. 20, Iss. 3, pp. 119-131
Closed Access | Times Cited: 1
β-Caryophyllene mitigates ischemic stroke-induced white matter lesions by inhibiting pyroptosis
Qing Xin, Fei Xu, Zegang Ma, et al.
Experimental Cell Research (2024) Vol. 442, Iss. 1, pp. 114214-114214
Closed Access | Times Cited: 1
Cannabinoid CB2 receptors modulate alcohol induced behavior, and neuro-immune dysregulation in mice
Berhanu Geresu Kibret, Aaliyah Roberts, Adam Kneebone, et al.
Behavioural Brain Research (2023) Vol. 448, pp. 114439-114439
Closed Access | Times Cited: 3
PET Imaging of the cannabinoid receptor type 2 in humans using [11C]MDTC
Yong Du, Jennifer M. Coughlin, Mary Katherine Brosnan, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 4
The next frontier in multiple sclerosis therapies: Current advances and evolving targets.
K. Trideva Sastri, Neha Gupta, Anbarasu Kannan, et al.
European Journal of Pharmacology (2024) Vol. 985, pp. 177080-177080
Closed Access
Activation of cannabinoid type 2 (CB2) receptors promotes the maintenance of redox homeostasis and protects against oxidative distress in the Neotropical freshwater fish matrinxã Brycon amazonicus (Characiformes: Bryconidae)
Suzana Luisa Alves Fernandes, Yan Costa Gonçalves, Francisco Tadeu Rantin, et al.
Neotropical Ichthyology (2024) Vol. 22, Iss. 4
Open Access
Impact of Cannabinoid Receptors in the Design of Therapeutic Agents against Human Ailments
Ankush Kumar, Ojasvi Gupta, Rohit Bhatia, et al.
Current Topics in Medicinal Chemistry (2023) Vol. 23, Iss. 19, pp. 1807-1834
Closed Access | Times Cited: 1
The Endocannabinoid System in the Central Nervous System: Emphasis on the Role of the Mitochondrial Cannabinoid Receptor 1 (mtCB1R)
Marisol Maya-López, Cecilia Zazueta, Socorro Retana‐Márquez, et al.
Springer eBooks (2021), pp. 1-23
Closed Access | Times Cited: 3
Alcohol induced behavioral and immune perturbations are attenuated by activation of CB2 cannabinoid receptors
Aaliyah Roberts, Mahli Christian, Lizbeth Nivar Dilone, et al.
Advances in Drug and Alcohol Research (2023) Vol. 3
Open Access
The Endocannabinoid System in the Central Nervous System: Emphasis on the Role of the Mitochondrial Cannabinoid Receptor 1 (mtCB1R)
Marisol Maya-López, Cecilia Zazueta, Socorro Retana‐Márquez, et al.
Springer eBooks (2022), pp. 565-587
Closed Access
Page 1

Scroll to top